---

As we outlined earlier this spring, congressional action on drug pricing continues to intensify. Key committees have advanced an array of reforms, demonstrating Congress’ intent to finalize legislation this year. We aim to clarify what that might include.
       

Source: The Commonwealth Fund: Blog - July 31, 2019 Category: International Medicine & Public Health Authors: Billy Wynne, Josh LaRosa, Alyssa Llamas Source Type: blogs